Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2011 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Lancet. 2017 Jun 10;389(10086):2317-2327. doi: 10.1016/S0140-6736(17)31429-0. Epub 2017 May 24.
Lancet. 2017.
PMID: 28551073
Clinical Trial.
Early-life risk factors and allergic rhinitis: comparing European and US data.
Ramsey AC, Deane PM.
Ramsey AC, et al.
J Allergy Clin Immunol. 2011 Oct;128(4):824-5. doi: 10.1016/j.jaci.2011.07.037. Epub 2011 Aug 11.
J Allergy Clin Immunol. 2011.
PMID: 21835444
No abstract available.
Item in Clipboard
Conifer pollen sensitivity in western New York: cedar pollens.
Deane PM.
Deane PM.
Allergy Asthma Proc. 2005 Sep-Oct;26(5):352-5.
Allergy Asthma Proc. 2005.
PMID: 16450568
Item in Clipboard
Cite
Cite